Skip to main content

Table 2 Regression analysis for the relationship between serum bilirubin levels and pulmonary functiona

From: Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease

 

FEV1, L

FVC, L

FEV1/FVC, %

estimated mean (SE)

P-value

estimated mean (SE)

P-value

estimated mean (SE)

P-value

Whole group

 Univariate

  Baseline bilirubin

0.08 (0.09)

0.382

0.18 (0.12)

0.121

− 0.52 (1.84)

0.776

  Clustered analysis

0.05 (0.09)

0.585

0.13 (0.11)

0.255

− 0.33 (1.75)

0.85

 Multivariateb

  Baseline bilirubin

0.04 (0.08)

0.607

0.11 (0.11)

0.322

−0.45 (1.72)

0.792

  Clustered analysis

0.02 (0.08)

0.798

0.05 (0.10)

0.662

0.08 (1.55)

0.959

GOLD I-II

 Univariate

  Baseline bilirubin

0.19 (0.09)

0.038

0.34 (0.14)

0.017

0.23 (1.76)

0.898

  Clustered analysis

0.14 (0.09)

0.115

0.21 (0.14)

0.116

1.21 (1.52)

0.428

 Multivariateb

  Baseline bilirubin

0.11 (0.08)

0.169

0.19 (0.12)

0.111

−0.08 (1.69)

0.962

  Clustered analysis

0.06 (0.07)

0.428

0.07 (0.12)

0.561

0.94 (1.36)

0.489

GOLD III-IV

 Univariate

  Baseline bilirubin

−0.04 (0.09)

0.622

−0.02 (0.18)

0.925

−0.52 (2.39)

0.829

  Clustered analysis

−0.11 (0.08)

0.169

−0.02 (0.15)

0.916

−2.79 (2.55)

0.273

 Multivariateb

  Baseline bilirubin

−0.07 (0.08)

0.349

−0.06 (0.17)

0.708

−0.91 (2.31)

0.694

  Clustered analysis

−0.12 (0.07)

0.103

−0.06 (0.14)

0.682

−2.59 (2.42)

0.285

  1. a ‘baseline bilirubin’ is the results of regression analysis for clinical outcomes according to the baseline bilirubin levels. ‘Clustured analysis’ is the results of regression analysis for clinical outcomes and repeated measured serum bilirubin levels
  2. b adjusted with age, sex, body mass index, smoking (current and former) FEV1 forced expiratory volume in 1 s, SE standard error, FVC forced vital capacity, GOLD Global Initiative for Chronic Obstructive Lung Disease